GB201415369D0 - Rapid screening and evaluation of diabetes and prediabetes by glycated haemoglobin mass spectrometry - Google Patents

Rapid screening and evaluation of diabetes and prediabetes by glycated haemoglobin mass spectrometry

Info

Publication number
GB201415369D0
GB201415369D0 GBGB1415369.6A GB201415369A GB201415369D0 GB 201415369 D0 GB201415369 D0 GB 201415369D0 GB 201415369 A GB201415369 A GB 201415369A GB 201415369 D0 GB201415369 D0 GB 201415369D0
Authority
GB
United Kingdom
Prior art keywords
prediabetes
diabetes
evaluation
mass spectrometry
rapid screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1415369.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ILES RAYMOND K
Original Assignee
ILES RAYMOND K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ILES RAYMOND K filed Critical ILES RAYMOND K
Priority to GBGB1415369.6A priority Critical patent/GB201415369D0/en
Publication of GB201415369D0 publication Critical patent/GB201415369D0/en
Priority to JP2017511664A priority patent/JP2017525972A/ja
Priority to PCT/GB2015/052487 priority patent/WO2016030687A1/en
Priority to CN201580046748.8A priority patent/CN107209189B/zh
Priority to EP15760506.4A priority patent/EP3186641B1/en
Priority to US15/506,731 priority patent/US10161941B2/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
GBGB1415369.6A 2014-08-29 2014-08-29 Rapid screening and evaluation of diabetes and prediabetes by glycated haemoglobin mass spectrometry Ceased GB201415369D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1415369.6A GB201415369D0 (en) 2014-08-29 2014-08-29 Rapid screening and evaluation of diabetes and prediabetes by glycated haemoglobin mass spectrometry
JP2017511664A JP2017525972A (ja) 2014-08-29 2015-08-27 グルコシル化ヘモグロビン質量分析法による糖尿病および前糖尿病の迅速なスクリーニングと評価
PCT/GB2015/052487 WO2016030687A1 (en) 2014-08-29 2015-08-27 Rapid screening and evaluation of diabetes and prediabetes by glycated hemoglobin mass spectrometry.
CN201580046748.8A CN107209189B (zh) 2014-08-29 2015-08-27 通过糖化血红蛋白质谱对糖尿病和前驱糖尿病的快速筛选和评价
EP15760506.4A EP3186641B1 (en) 2014-08-29 2015-08-27 Rapid screening and evaluation of diabetes and prediabetes by glycated hemoglobin mass spectrometry
US15/506,731 US10161941B2 (en) 2014-08-29 2015-08-27 Rapid screening and evaluation of diabetes and prediabetes by glycated hemoglobin mass spectrometry

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1415369.6A GB201415369D0 (en) 2014-08-29 2014-08-29 Rapid screening and evaluation of diabetes and prediabetes by glycated haemoglobin mass spectrometry

Publications (1)

Publication Number Publication Date
GB201415369D0 true GB201415369D0 (en) 2014-10-15

Family

ID=51752373

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1415369.6A Ceased GB201415369D0 (en) 2014-08-29 2014-08-29 Rapid screening and evaluation of diabetes and prediabetes by glycated haemoglobin mass spectrometry

Country Status (6)

Country Link
US (1) US10161941B2 (enExample)
EP (1) EP3186641B1 (enExample)
JP (1) JP2017525972A (enExample)
CN (1) CN107209189B (enExample)
GB (1) GB201415369D0 (enExample)
WO (1) WO2016030687A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019074954A1 (en) * 2017-10-09 2019-04-18 Lifestory Health, Inc. SELECTING BIOMARKERS IN BODY FLUIDS FOR PATIENT STRATIFICATION AND APPLICATION OF A PRECISION MEDICAMENT THROUGH NOVEL DIAGNOSTIC BIOMARKERS
WO2019099948A1 (en) * 2017-11-17 2019-05-23 Bio-Rad Laboratories, Inc. Smart advisor for blood test evaluation
US20210239717A1 (en) * 2018-08-22 2021-08-05 Quest Diagnostics Investments Llc Microsampling detection in diabetes
CN110133280B (zh) * 2019-04-29 2022-05-20 融智生物科技（青岛）有限公司 一种β链变异的血红蛋白糖化率的测定方法
CN110658251A (zh) * 2019-10-01 2020-01-07 长沙湘华质谱医学科技有限公司 表征地中海贫血症的特征蛋白组合物或质谱模型的用途
CN111638261B (zh) * 2020-04-17 2023-04-07 融智生物科技（青岛）有限公司 一种计算设备、存储介质和地中海贫血筛查装置及系统
CN114527190A (zh) * 2022-01-14 2022-05-24 融智生物科技（青岛）有限公司 一种糖化血红蛋白检测试剂盒及其检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847209A (en) * 1987-11-09 1989-07-11 Miles Inc. Latex agglutination immunoassay in the presence of hemoglobin
US20040171026A1 (en) * 2001-09-05 2004-09-02 Hochstrasser Denis Francois Diagnostic method for transmissible spongiform encephalopathies
TW200538738A (en) * 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
WO2005116607A1 (en) * 2004-05-27 2005-12-08 Monash University A method for the rapid analysis of polypeptides
WO2007117794A2 (en) * 2006-03-06 2007-10-18 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Glycated peptides and methods of use
JP2007263896A (ja) * 2006-03-29 2007-10-11 Univ Nagoya 肺癌患者の術後予後予測のための生物マーカー及びその方法
US7951776B2 (en) * 2006-09-01 2011-05-31 American Type Culture Collection Methods for treatment of type 1 diabetes
US9250248B2 (en) * 2006-11-01 2016-02-02 The Johns Hopkins University Early detection of diabetes
JP2011515680A (ja) * 2008-03-17 2011-05-19 ネルソン，ランドール，ダブリュ． 糖尿病のためのバイオマーカーおよびアッセイ
WO2009144229A1 (en) * 2008-05-27 2009-12-03 F. Hoffmann-La Roche Ag Method for risk reduction in glycemic control
CA2765457A1 (en) * 2009-07-07 2011-01-13 Uvic Industry Partnerships Inc. Methods for early detection of blood disorders
SG195180A1 (en) 2011-05-31 2013-12-30 Singapore Health Serv Pte Ltd Method for detecting disease biomarkers
AU2014210871A1 (en) * 2013-01-31 2015-08-13 Adaerata, Limited Partnership Type 2 diabetes biomarkers and uses thereof

Also Published As

Publication number Publication date
US10161941B2 (en) 2018-12-25
US20170254814A1 (en) 2017-09-07
JP2017525972A (ja) 2017-09-07
WO2016030687A1 (en) 2016-03-03
CN107209189A (zh) 2017-09-26
EP3186641B1 (en) 2019-07-17
CN107209189B (zh) 2019-06-14
EP3186641A1 (en) 2017-07-05

Similar Documents

Publication Publication Date Title
GB2554180B (en) Spectrometric analysis
GB2556451B (en) Dual mode mass spectrometer
GB2602212B (en) Spectrometric analysis
EP3350664A4 (en) MICRO-MOMENT ANALYSIS
EP3148662A4 (en) Extraction, derivatization, and quantification of analytes
GB201411840D0 (en) MOnitoring biomolecule separations by mass spectrometry
GB201408392D0 (en) Mass Analyser
EP3166129A4 (en) Mass spectrometer
GB2570435B (en) Mass spectrometer
GB201415369D0 (en) Rapid screening and evaluation of diabetes and prediabetes by glycated haemoglobin mass spectrometry
EP3196640A4 (en) Mass spectrometer
EP3096135A4 (en) Mass spectrometer
GB201516508D0 (en) Mass spectrometer
EP3287530A4 (en) Method for analyzing biomolecule by using external biomolecule as standard material, and kit therefor
SG11201707611SA (en) Forensic analysis
GB201518477D0 (en) Biomolecule separation and modification
GB2559527B (en) Mass spectrometer
GB201615469D0 (en) Mass spectrometry
EP3364185A4 (en) Mass spectrometer
EP3607577A4 (en) MASS ANALYZER
GB2602769B (en) Analysis of Isomers in TIMS-Q-q-TOF Mass Spectrometers
SG11201700893WA (en) Biomolecule analyzer
GB2529748B (en) Staggered chromatography mass spectrometry
GB2556225B (en) Sample mass spectrum analysis
GB2535826B (en) Mass spectrometers

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)